SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-016284
Filing Date
2023-10-06
Accepted
2023-10-06 16:30:18
Documents
12
Period of Report
2023-10-03
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K aytu-20231003x8k.htm   iXBRL 8-K 32490
  Complete submission text file 0001558370-23-016284.txt   151557

Data Files

Seq Description Document Type Size
2 EX-101.SCH aytu-20231003.xsd EX-101.SCH 3130
3 EX-101.LAB aytu-20231003_lab.xml EX-101.LAB 15902
4 EX-101.PRE aytu-20231003_pre.xml EX-101.PRE 10059
6 EXTRACTED XBRL INSTANCE DOCUMENT aytu-20231003x8k_htm.xml XML 4862
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38247 | Film No.: 231314550
SIC: 2834 Pharmaceutical Preparations